Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
San Antonio, TX
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Alexandria, VA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Seattle, WA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Daytona Beach, FL
Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Dallas, TX
Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Status: Enrolling
Updated:  2/5/2016
South Drive Medical Clinic
mi
from
Mountain View, CA
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Status: Enrolling
Updated: 2/5/2016
South Drive Medical Clinic
mi
from
Mountain View, CA
Click here to add this to my saved trials
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Status: Enrolling
Updated:  2/5/2016
Clinvest
mi
from
Springfield, MO
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
Status: Enrolling
Updated: 2/5/2016
Clinvest
mi
from
Springfield, MO
Click here to add this to my saved trials
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Status: Enrolling
Updated:  2/10/2016
UCLA Pediatric Pain Management Clinic
mi
from
Los Angeles, CA
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Status: Enrolling
Updated: 2/10/2016
UCLA Pediatric Pain Management Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
UCLA School of Medicine
mi
from
Los Angeles, CA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Memorial Hospital
mi
from
Colorado Springs, CO
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Memorial Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Swedish Medical Center
mi
from
Englewood, CO
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Medical Center of the Rockies
mi
from
Fort Collins, CO
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Medical Center of the Rockies
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
MedStar Washington Hospital Center
mi
from
Washington,
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
University of Iowa
mi
from
Iowa City, IA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
University of Kentucky
mi
from
Lexington, KY
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Tufts Medical Center
mi
from
Boston, MA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
St. Cloud Hospital
mi
from
St. Cloud, MN
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
St. Cloud Hospital
mi
from
St. Cloud, MN
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
St. Johns's Mercy Medical Center
mi
from
St. Louis, MO
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
St. Johns's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Children's Heart Center Las Vegas
mi
from
Las Vegas, NV
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Children's Heart Center Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Mercy Hospital of Buffalo
mi
from
Buffalo, NY
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Mercy Hospital of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
University of Rochester Medical School
mi
from
Rochester, NY
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
University of Rochester Medical School
mi
from
Rochester, NY
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Pinnacle Health Hospitals
mi
from
Harrisburg, PA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Pinnacle Health Hospitals
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
St. Mark's Hospital
mi
from
Salt Lake City, UT
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
St. Mark's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Inova Healthcare Services
mi
from
Falls Church, VA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Inova Healthcare Services
mi
from
Falls Church, VA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
University of Washington Medical Center
mi
from
Seattle, WA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
The Mayo Clinic
mi
from
Rochester, MN
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Methodist Hospital
mi
from
Houston, TX
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Status: Enrolling
Updated:  2/15/2016
Yale Physician's Building, 800 Howard Ave, lower level
mi
from
New Haven, CT
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Status: Enrolling
Updated: 2/15/2016
Yale Physician's Building, 800 Howard Ave, lower level
mi
from
New Haven, CT
Click here to add this to my saved trials
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
Status: Enrolling
Updated:  2/15/2016
Clinical Research Facility
mi
from
Raleigh, NC
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
Status: Enrolling
Updated: 2/15/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
James D. Wolfe, MD
mi
from
San Jose, CA
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
James D. Wolfe, MD
mi
from
San Jose, CA
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Avail Clinical Research
mi
from
DeLand, FL
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Nathan Segall, MD, CPI
mi
from
Stockbridge, GA
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Nathan Segall, MD, CPI
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Gary D. Berman, MD
mi
from
Minneapolis, MN
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Gary D. Berman, MD
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
John Rubino, MD
mi
from
Raleigh, NC
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
John Rubino, MD
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Stephan C. Sharp, MD
mi
from
Nashville, TN
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Stephan C. Sharp, MD
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated:  2/26/2016
Duane G. Wombolt, MD
mi
from
Norfolk, VA
Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Status: Enrolling
Updated: 2/26/2016
Duane G. Wombolt, MD
mi
from
Norfolk, VA
Click here to add this to my saved trials